Innovation Pharmaceutical Technology is for Laboratorios Betamore than a simple statement, actually it is the foundation itself of its growth strategy.
This concept admits that the industry’s success is closely linked to the ability of incorporating the scientific know-how into the technological innovation andthrough
modern management these effective tools may help to obtain the preestablished objective, that is the placement on the market of safe and effective products that contribute to community welfare.
The research and development team is strategically integrated with the IP Department, Medical Direction and Pharma Division. This was implemented by the firm to progress to a more advanced stage of development and commercialization of new products.
Laboratorios Beta’s growth is mainly based either on the introduction of new dosage forms for known therapeutic entities or on the launching of new molecules within the framework of the law of the patents.
Many difficulties should be usually overcome so that the effort of our scientists and professionals results in business opportunities.
We are obliged to evaluate carefully every pharmaceutical project according to the patent legislation in force.We are permanently evaluating not only all patent risks
but also the patentability of our inventions.
Laboratorios Beta is currently planning the installation of a biotechnological plant.This will be the unique plant in Argentina devoted to the production of recombinant human insulin among other biotechnological molecules.
Beta rises to the occasion of the current demands having the appropriate infrastructure, know-how and the necessary determination to face the challenges.
